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Diet, exercise, and pharmacological interventions have limited effects in counteracting the
worldwide increase in pediatric body weight. Moreover, the promise that individualized
drug design will work to induce weight loss appears to be exaggerated. We suggest that
the reason for this limited success is that the cause of obesity has been misunderstood.
Body weight is mainly under external control; our brain permits us to eat under most
circumstances, and unless the financial or physical cost of food is high, eating and body
weight increase by default. When energy-rich, inexpensive foods are continually available,
people need external support to maintain a healthy body weight. Weight loss can thereby
be achieved by continuous feedback on how much and how fast to eat on a computer
screen.
Keywords: children, body weight, brain, genes, eating behavior
INTRODUCTION
The medical consequences of overweight and obesity in adults and children alike are well known
(1–3), and although attempts to curb further escalation of the problem have met with some limited
success (4–7), childhood obesity continues to increase throughout the world (8). Given that the
biological mechanisms that contribute to weight regulation are complex (9–12) it is a challenge to
treat obesity (13–15).
Public health initiatives, e.g., making people eat low-calorie foods and banning fast food commer-
cials (16–18) and/or increasing their exercise level, e.g., implementing exercise programs at school
(6, 16, 19), have also met with some success. Most attempts at developing obesity drugs have been
abandoned owing to unwanted adverse effects (20); drug-induced body weight loss is most often
<6% (21–23). New hope for weight-loss drug development has been ignited by “precision medicine”
(24). This approach, which is based on an understanding of individual genetics, has been successful
in managing some forms of cancer; the question is whether it can be used to develop individualized
drugs to treat obesity, given the complexity of the interaction between genes and environment in
human behaviors (25–27).
What is known, however, is that gastric surgery reduces body weight of both adults and children
(28). Interestingly, the effect in obese mice appears not to be due to the decrease in gastric size,
but to an increase in bile acids and their associated changes in intestinal microbe populations (29).
Mimicking these effects pharmacologically might work with obese humans, and may even prevent
the re-emergence of type-2 diabetes, which has been reported after bariatric surgery, despite the
maintenance of a reduced body weight (30, 31). Although mimicking the physiology of weight loss
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with drugs has proved to be an ineffective strategy, it may be
possible to mimic the change in bile acids to induce weight loss, a
possibility supported by an impressive, comprehensive analysis of
this subject (32).
We suggest, however, that the reason why most approaches to
effect weight loss have failed is that the causes of obesity have
been misunderstood and that our present understanding of how
the neuroendocrine system is engaged in eating and body weight
regulation is mistaken.
YOU ARE NOT WHAT YOU EAT
Although it was reported that counseling aiming at reducing
caloric intake and increasing physical activity in two large groups
of overweight and obese patients had negligible effects (33, 34),
it was observed that behavioral factors, rather than macronutri-
ent composition, are the main influences on weight loss. Some
support for modifying eating behavior to induce weight loss was
noted in a large-scale project with children (35, 36), but com-
pelling results have not yet been published from this project. A
recently published meta-analysis of the available data indicated
that diet and exercise interventions have very small, albeit possibly
clinically significant, effects on body weight (37). The specific
content of diet appears unimportant, but what is important is
patient compliance (36). However, it is axiomatic that those who
are able to eat less food will lose weight and that those who are not
able to do that, will not lose weight. Although some have found
that an increase in physical activity combined with a reduction in
calorie intake can result in a modest decrease in body weight (37),
this feat is rarely accomplished. Moreover, others have concluded
that calorie restriction with increased exercise is no better than
calorie restriction alone (38).
THE BRAIN DOES NOT CONTROL EATING
TO MAINTAIN A CONSTANT BODYWEIGHT
More than 100 years ago, it was discovered that hypothalamic
damage is associated with changes in body weight. The subse-
quent experimental research on this topic concluded that there are
dual hypothalamic centers that either induce or inhibit eating to
maintain a constant body weight (39). A similar model of body
weight control remains today, with the exception that while exci-
tation and inhibition of eating behavior were originally thought
to be only anatomically separable, they are now considered to be
both chemically and anatomically distinct (40, 41). Body weight
is thought to be kept stable through the activity of orexigenic
and anorexigenic signaling molecules that respond to feedback
from adipose tissue, the pancreas, and the gastrointestinal tract
(42). But rather than being maintained at a constant level home-
ostatically, body weight is drifting upward all over the world –
hypothalamic anorexigens that signal satiety are clearly unable to
arrest this development.
The problems with the hypothalamic model of food intake
emerge when attempts are made to translate this concept into the
clinic. Thus, most purported orexigens, which should increase
food intake, are elevated in patients with anorexia nervosa, yet
these patients rarely eat (43). And when anorexic patients eat
more food, their blood levels of an anorexigen, such as leptin,
increases (44). An inhibitor of food intake, of course, should not
be found at high levels at a time of increased food intake. Con-
versely, since obese patients have elevated levels of the purported
anorexigen leptin, and they continue to eat large amounts of food
(45), leptin cannot be an anorexigen. To rescue the concept of
orexigens/anorexigens, it has been suggested that obese patients
are insensitive to leptin. However, insensitivity to leptin is a fragile
idea because: (1) the sensitivity to leptin can be restored with
amylin treatment, (2) the brains of experimental animals eating
a high-fat diet are as sensitive to leptin as are the brains of animals
eating a low-fat diet, and (3) while sensitivity to leptin can be
suppressed in one brain area, it can be retained in another (46).
To some extent, therefore, these conceptual problems are cre-
ated by the outdated hypothalamic homeostatic framework. It
would be very surprising indeed if the cause of obesity is found
in the presumably abnormal brains of the hundreds of millions of
people who are now obese. Their brains are probably simply doing
what they have evolved to do, and the cause of their problem is
more likely outside than inside of their body (47). Body weight
was kept low over millennia through the lack of easily available
food (48). Hence, all animals, including humans, have evolved
efficient behavioral strategies foraging for food (49), and these
strategies can be studied experimentally. Thus, by dissociating the
behavioral responses for foraging for food (appetitive behavior)
from those employed for eating food (consummatory behavior)
in laboratory animals, it was discovered that neuropeptide tyro-
sine, a “hypothalamic orexigen,” stimulated the search for food
at the expense of eating, and that leptin, generally recognized
as an inhibitor of eating, markedly increased eating when the
need to search for food was circumvented (50). These results
are inconsistent with the hypothalamic homeostatic framework,
but consistent with the behavioral and clinical phenotypes of
underweight and overweight patients (51).
However, a remarkable recent demonstration that activation
of a mere 800 hypothalamic neurons evoked voracious feeding
within minutes in mice compelled the authors to conclude that
these neurons serve a “dedicated role coordinating this com-
plex behavior” (52), inducing renewed optimism: “the future of
hypothalamic research is clearly bright” (53). However, this con-
clusion was rapidly challenged by the even more recent finding
that the same cell groups were activated immediately upon pre-
sentation of food to a mouse, but before it started to eat, per-
suading these authors to suggest that these neurons were involved
in appetitive, rather than consummatory behaviors (9, 42), con-
firming the findings of Ammar et al. (50). However, the authors
were perhaps inaccurate in suggesting that the neurons that were
studied actually control appetitive behavior. Instead, it was clear
that the neurons responded to the presentation of food, and as
a consequence, the animal engaged in appetitive behavior; the
neurons were controlled by the environment. The importance
of such neurobiological adaptation to environmental changes as
related to eating has long been known (54, 55).
These recent studies support the hypothesis that the brain
permits, rather than controls eating, and that eating and body
weight are controlled externally, with the major regulatory factor
being the physical and economic price of the food (47, 48, 51,
56, 57). Because hypothesized hypothalamic orexigens can turn
into anorexigens in response to a change in the environment
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(48), drugs developed to decrease eating might actually increase
eating when that change occurs. For this reason, the utility of the
pharmacological approach to the control of eating behavior and
body weight will probably continue to be minimal (58, 59).
ENTER PRECISION MEDICINE
It has recently been suggested that obesity is the result of a
chronically disordered brain (60). On this perspective, the brain is
thought to reprioritize behavior outputs and increase food intake
independent of energy stores in the form of body fat (61). More
plausibly, eating a great deal of food should be considered to
be a normal response to palatable, easily accessed food (47, 62).
Encouraging people to make healthy food choices (63) should
therefore be expected to fail.
The risk of obesity is also thought to be due in part to genetic
factors (61). According to a recent report, 97 gene loci are related
to the control of body weight, including genes involved with
specific pathways in the brain that engage multiple neurotrans-
mitter systems (64). In order to take all of these factors into
consideration, precision medicine would have to develop perhaps
hundreds of drugs to reliable produce weight loss. The promise
that this approach will solve most problems related to obesity
seems unlikely.
However, we know that the major factor that prevented an
increase in body weight throughout the world was the poor avail-
ability of food (49). Humans also evolved to run for long distances
to be able to capture wild game to support their life, but today such
routine exercise is rarely part of daily life, impacting negatively on
health (65). It has been suggested that the search for the candidate
genes for the human homeostatic phenotype that would allow
the maintenance of a constant body weight should consider the
ways in which glycogen and triglycerides are stored in skeletal
muscle, a key to optimal physical activity (66). Skeletal muscle
fitness has since been elegantly analyzed and has been associated
with both cardiovascular and mental health (67, 68). However,
although exercise genomics as it relates to metabolic health is
making impressive progress (69), even the genes of theworld’s best
runners (70) do not protect their carriers from the effects of living
in an easy food environment (71).
YOU ARE HOW YOU EAT
Thus, our brain and genes permit rather than control eating, and
because evolution has not encouraged satiety, we eat in most
circumstances, and unless we have to work for the food, our
body weight increases (51). Unsurprisingly, attempts at dieting
also increase, but rather than having the desired effect, dieting
increases the risk for losing control and gaining even more weight
(72). We have suggested, therefore, that today when inexpensive
high-energy foods are continually available at low cost, we need
external support to eat a normal amount of food and maintain a
healthy low body weight (47).
A treatment for childhood and adolescent obesity that relies
on this perspective was an adjustment of a treatment for under-
weight patients, who had been diagnosed with anorexia nervosa.
Addressing their disordered eating behavior directly was shown to
be effective in a randomized controlled trial with a remission rate
of 75% in on average 1 year of treatment and a rate of relapse of
10% over 5 years of follow-up (73, 74). Anorexia typically develops
at 14–19 years of age and the patients in our studies were on
average 17.5 years old, having been diagnosed on average 3.2 years
earlier (74). However, it is important that the treatment is effective
inmost age groups, and therefore, age is not an exclusion criterion.
A critical part of therapy is giving them mealtime feedback on
their speed of eating. Anorexics eat very little food very slowly,
and they use the feedback to practice eating more food at a
higher speed. The feedback shows their speed of eating on a small
monitor next to the normal rate of consumption of such a meal.
In an effort to treat obese adolescents and children, this same
approach was used, with the exception that the rapid food intake
of such individuals was normalized with the mealtime feedback
(75). The underlying assumption is that anorexia and obesity are
the extreme opposites with the same behavioral problem; both
have lost control over the speed at which they eat their food
(51). It should be noted, however, that although eating quickly is
associated with overconsumption of food (76), it has not yet been
demonstrated quantitatively that the obese actually eat quickly.
And if they do, the cause–effect relationship between eating speed
and obesity remains to be determined.
A randomized controlled trial showed that reducing the speed
of eating decreased the food intake and the body weight of obese
12.5 years old more effectively than a standard diet intervention,
and, interestingly, the effect was maintained over 6months of
follow-up (75). Relapse into obesity, which is all too common,
is hypothetically caused by irreversible biological changes, such
as elevated levels of ghrelin, a purported hunger hormone (11,
77). However, treating eating behavior directly reduced, rather
than increased the level of ghrelin [Figure 1 (78, 79)]. Changes in
FIGURE 1 | Fasting concentrations of ghrelin in 13 adolescents who
received a standard diet intervention for 12months, and in 14 who
practiced eating at a reduced speed for 12months. The children were on
average 12.5 years old, the values are mean (SD).
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FIGURE 2 | Food intake during the school lunch in 18 girls and 12
boys. The children had their speed of eating experimentally increased,
unchanged, or decreased in relation to its value in a meal eaten without
constraints, the values are expressed as percent of that value. Green lines
indicate individuals able to maintain their food intake independent of the
speed of eating. The children were on average 13 years old.
endocrine secretions through experimentally induced changes in
behavior, such as the effect of an alteration in eating behavior on
ghrelin, show that this principle can be translated into the clinical
management of childhood obesity.
A change in eating behavior can be caused by an environmental
change. For example, the limited amount of time available for
eating lunch forces school children to eat quickly. Thus, 100,
on average 13 years old, children spent on average just 7min
eating their school lunch with their peers (80). A more detailed
study showed that 18 girls ate their lunch in as little as 5.6min
and 12 boys ate theirs in a mere 6.8min. Only two girls and
one boy were able to maintain their food intake at the level
observed when they ate individually (258 g in girls and 289 g in
boys). Nine girls ate on average 33% less food and seven girls
ate 23% more food, whereas the remaining boys ate 26% more
food when eating their school lunch rapidly with their class mates
(Figure 2). The average speed of eating increased to 183% in
the girls and to 166% in the boys compared to when they were
eating individually. These changes in food intake during school
lunches were replicated by experimentally increasing the speed
of eating when the children were eating individually (Figure 2)
(80). Thus, most boys and half of the girls eat too much when
forced to eat quickly; only a few are able to eat a normal amount
of food.
The main risk factor for loss of control – dieting – also causes
a sexually dimorphic change in eating behavior. Although men
who skipped dinner eat more food quickly the next day, women
eat less food the next day at a constant speed (81). If maintained,
this pattern of eating results in a further loss of control; when
women who eat at the same speed throughout their meal are
forced to eat quickly, they over-eat. Conversely, when forced to
eat slowly, they under-eat (82). They rapidly adopt the pattern of
eating characteristic of obese patients and anorexics, who both
eat at a constant speed (83). Interestingly, using the feedback
method discussed above, anorexic and obese patients are able
to eat normal-size meals at the normal speed, suggesting that
the biological changes associated with these individuals do not
prevent them from eating normally (81, 82).
CONCLUDING REMARKS
It is probably normal to eat large quantities of food when eating is
easy. Most people, therefore, need external support to eat a proper
amount of food and maintain a healthy low body weight. Such
support can be provided by feedback on a computer screen to
both under- and over-weight patients. This method has brought
hundreds of patients with eating disorders into remission (74)
and is presently used effectively with obese children and adults.
It must be added, however, the effects of new methods need to be
further evaluated and followed up before they are implemented
into health-care systems.
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